News
The global Immune Repertoire Sequencing Market, valued at US$344.2 million in 2024, is forecasted to grow at a robust CAGR of 9.6%, reaching ...
The global Immune Repertoire Sequencing Market, valued at US$344.2 million in 2024, is forecasted to grow at a robust CAGR of 9.6%, reaching US$354.6 million in 2025 and an impressive US$560.5 million ...
The global Immune Repertoire Sequencing Market, valued at US$344.2 million in 2024, is forecasted to grow at a robust CAGR of 9.6%, ...
Recently, Professor Frédéric Veyrier at the Institut national de la recherche scientifique (INRS) and his team developed a new genetic tool based on a family of specific enzymes called Ssn that allows ...
The Global Single Cell Analysis Market achieved a valuation of $4.90 Billion in 2024 and is anticipated to exceed $21.97 Billion by 2035, reflecting a compounded annual growth rate (CAGR) of 16.55% ...
Even if they like it, they won’t put a ring on it. There’s a reason why there are so many single ladies these days, according to experts. “There’s been a simple but profound shift in the ...
The company manufactures instruments, consumables, and software for whole-genome sequencing, exome sequencing, and single-cell transcriptomics. The Chromium platform developed by 10x Genomics is ...
Founded in 2012, 10x Genomics (NASDAQ ... and also consumables alongside the software. Its Chromium platform allows for single-cell analysis, while its Visium and Xenium enable spatial analysis.
In 2024, 10x Genomics worked to cement its status as “the single-cell analysis company,” making upgrades and additions to its portfolio of tools used by researchers in academia and industry to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results